Next Article in Journal
Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target
Next Article in Special Issue
Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine
Previous Article in Journal
Influence of CYP2C9 Genetic Polymorphisms on the Pharmacokinetics of Losartan and Its Active Metabolite E-3174: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis
 
 
Review

Article Versions Notes

J. Pers. Med. 2021, 11(7), 618; https://doi.org/10.3390/jpm11070618
Action Date Notes Link
article pdf uploaded. 29 June 2021 17:29 CEST Version of Record https://www.mdpi.com/2075-4426/11/7/618/pdf-vor
article pdf uploaded. 29 June 2021 17:36 CEST Updated version of record https://www.mdpi.com/2075-4426/11/7/618/pdf-vor
article xml file uploaded 30 June 2021 04:36 CEST Original file -
article xml uploaded. 30 June 2021 04:36 CEST Update https://www.mdpi.com/2075-4426/11/7/618/xml
article pdf uploaded. 30 June 2021 04:36 CEST Updated version of record https://www.mdpi.com/2075-4426/11/7/618/pdf
article html file updated 30 June 2021 04:37 CEST Original file -
article html file updated 27 July 2022 02:41 CEST Update https://www.mdpi.com/2075-4426/11/7/618/html
Back to TopTop